KaydedilenlerDerginizi ekleyin

Dergiler / Türk Onkoloji Dergisi / 2021 / Cilt: 36 - Sayı: 4

Role of Radiotherapy in Vulvar Squamous Cell Carcinoma: Review of the Literature

Ferah YILDIZ
Çağlayan Selenge BEDÜK ESEN
Melis GÜLTEKİN
Sayfa
529–537
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this current review, we will discuss the rationale of RT and provide up-to-date information about the role of RT in the treatment of vulvar cancer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:En bloc radical vulvectomy with bilateral inguinofemoral lymph node dissection was the standard approach for patients diagnosed with vulvar cancer, regardless of disease extent in the past.
📊
Temel Bulgular & Veri:This radical surgical approach was with high rates of morbidity and adverse psychological effects and led to insufficient locoregional control rates in patients with locally advanced-stage disease.
💡
Sonuç & Katkı:In this current review, we will discuss the rationale of RT and provide up-to-date information about the role of RT in the treatment of vulvar cancer.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

En bloc radical vulvectomy with bilateral inguinofemoral lymph node dissection was the standard approach for patients diagnosed with vulvar cancer, regardless of disease extent in the past. This radical surgical approach was with high rates of morbidity and adverse psychological effects and led to insufficient locoregional control rates in patients with locally advanced-stage disease. In recent years, multimodal treatment approaches have been introduced to decrease treatment-related morbidity and increase the locoregional control rates. Radiotherapy (RT) has a major role in the treatment of vulvar cancer. It has been successfully used as an adjuvant approach in patients with high risk of local recurrence after surgery and as a sole local treatment with concomitant chemotherapy in locally advanced disease. In this current review, we will discuss the rationale of RT and provide up-to-date information about the role of RT in the treatment of vulvar cancer.

🔖

Bu Makaleye Atıf Yap

YILDIZ, F., ESEN, Ç. S. B., GÜLTEKİN, M. (2022). Role of Radiotherapy in Vulvar Squamous Cell Carcinoma: Review of the Literature. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 4, 529–537. https://ajindex.com/articles/639079

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021;71(1):7–33
  2. Schuurman MS, van den Einden LC, Massuger LF, Kiemeney LA, van der Aa MA, de Hullu JA. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer 2013;49:3872– 80
  3. Bethesda M. SEER Cancer Statistics Factsheets: Vulvar Cancer. Tamil Nadu: NIH; 2021
  4. Bornstein J, Bogliatto F, Haefner HK, Stockdale CK, Preti M, Bohl TG, et al. The 2015 international society for the study of vulvovaginal disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. J Low Genit Tract Dis 2016;20(2):11–4
  5. Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina--populationbased case-control study in Denmark. Int J Cancer 2008;122(12):2827–34
  6. Zapardiel I, Iacoponi S, Coronado PJ, Zalewski K, Chen F, Fotopoulou C, et al. Prognostic factors in patients with vulvar cancer: The VULCAN study. Int J Gynecol Cancer 2020;30(9):1285–91
  7. Yap J, O’Neill D, Nagenthiran S, Dawson CW, Luesley DM. Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva. BJOG 2017;124(6):946–54
  8. Cheng X, Zang R, Wu X, Li Z, Cai S, Zhang Z. Recurrence patterns and prognostic factors in Chinese patients with squamous cell carcinoma of the vulva treated with primary surgery. Int J Gynecol Cancer 2009;19(1):158–62
  9. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 1960;79:692–7. 10.Soliman AA, Heubner M, Kimmig R, Wimberger P. Morbidity of inguinofemoral lymphadenectomy in vulval cancer. ScientificWorldJournal 2012;2012:341253. 11.Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemoral dissection for carcinoma of the vulva: Effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 2003;196(3):442–50. 12.Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000;2000(2):CD002036. 13. van der Velden J, Schilthuis MS, Hyde SE, Ten Kate FJ, Burger MP. Squamous cell cancer of the vulva with occult lymph node metastases in the groin: The impact of surgical technique on recurrence pattern and survival. Int J Gynecol Cancer 2004;14(4):633–8. 14.Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: Further